UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
--------------------------------------------------------------------------------
                                    FORM 10-Q
--------------------------------------------------------------------------------

     [X]  QUARTERLY  REPORT  PURSUANT  TO SECTION 13 OR 15(d) OF THE  SECURITIES
          EXCHANGE ACT OF 1934

                For the quarter period ended September 30, 2003

                                       OR

     [ ]  TRANSITION  REPORT  PURSUANT TO SECTION 13 OR 15(d) OF THE  SECURITIES
          EXCHANGE ACT OF 1934

             For the transition period from ___ to ___

                           Commission File No. 0-27654

--------------------------------------------------------------------------------
                   LONG ISLAND PHYSICIAN HOLDINGS CORPORATION
             (Exact name of registrant as specified in its charter)

            New York                                           11-3232989
  (State or other jurisdiction                              (I.R.S. Employer
of incorporation or organization)                        Identification Number)

  One Huntington Quadrangle Suite 4C-01
           Melville, New York                                     11747
(Address of principal executive offices)                       (Zip Code)

       Registrant's telephone number, including area code: (631) 454-1900

        Securities registered pursuant to Section 12(b) of the Act: None

           Securities registered pursuant to Section 12(g) of the Act:

                      Class A Common Stock, par value $.001
                      Class B Common Stock, par value $.001

      Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the past 12 months (or for such shorter period that the issuer was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes [ ] No [X]

      Indicate by check mark whether the registrant is an accelerated filer (as
      defined under Rule 12b-2 of the Act). Yes __ No X.

      Indicate the number of shares outstanding of each of the Registrant's
classes of Common Stock, as of the latest practicable date: As of September 30,
2003 there were 1,506 shares of Class A common stock and 4,333 shares of Class B
common stock outstanding.

<PAGE>

                                TABLE OF CONTENTS

                                                                        Page No.
                                                                        --------

PART I   FINANCIAL INFORMATION (UNAUDITED)

Item 1.   Financial Statements

         Consolidated Balance Sheets                                         2
         Consolidated Statements of Operations and Accumulated Deficit       3
         Consolidated Statements of Cash Flows                               4
         Notes to Consolidated Financial Statements                        5-9

Item 2. Management's Discussion and Analysis of Financial Condition
        and Results of Operations                                        10-17

Item 3. Quantitative and Qualitative Disclosures About Market Risk          17

Item 4. Controls and Procedures                                             17

PART II OTHER INFORMATION

Item 1. Legal Proceedings                                                   18

Item 5. Other Information                                                   18

Item 6. Exhibits and Reports on Form 8-K                                    18

SIGNATURES                                                                  19

CERTIFICATIONS


                                       1
<PAGE>

                         PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

                   Long Island Physician Holdings Corporation
                           Consolidated Balance Sheets
                    September 30, 2003 and December 31, 2002
                                   (unaudited)

                                                   September 30,   December 31,
                                                       2003            2002
                                                   ------------    ------------
Assets
Current assets:
 Cash and cash equivalents                         $     38,105    $    694,449
 Premium receivables (net of allowances of
 approximately $1,530,000 in 2003 and $961,000 in
 2002)                                               12,746,779       8,699,338
 Reinsurance recoverable                                518,337         635,420
 Payments in excess of capitation                     2,999,251       2,999,251
 Other assets                                         3,385,455       3,205,406
                                                   ------------    ------------
     Total current assets                            19,687,927      16,233,864

 Restricted cash and investments                      5,586,683       5,657,135
 Property plant & equipment                             295,545         392,245
 Payments in excess                                  17,698,817      19,215,858
 Due from CHSLI                                       2,382,027       2,382,027
                                                   ------------    ------------
     Total assets                                  $ 45,650,999    $ 43,881,129
                                                   ------------    ------------

Liabilities and stockholder's equity
Current liabilities:
 Medical claims payable                            $ 26,154,285    $ 28,967,021
 Public goods payable                                 7,198,063       5,367,150
 Unearned premium revenue                             1,798,698       1,955,180
 Accounts payable and accrued expenses                2,870,929       2,246,652
 Current portion of capital leases                        1,926          14,324
                                                   ------------    ------------
     Total current liabilities                       38,023,901      38,550,327

Long term debt and accrued interest                   3,321,862       3,247,150
                                                   ------------    ------------
     Total liabilities                               41,345,763      41,797,477
                                                   ------------    ------------

Minority interest                                     1,987,566       1,247,315

Stockholders' equity:
Common stock                                                  6               6
Additional paid in capital                           11,478,536      11,478,536
Accumulated deficit                                  (9,160,872)    (10,642,205)
                                                   ------------    ------------
     Total stockholders' equity                       2,317,670         836,337
                                                   ------------    ------------
     Total liabilities and stockholder's
     equity                                        $ 45,650,999    $ 43,881,129
                                                   ============    ============

The accompanying notes are an integral part of these statements


                                       2
<PAGE>

                   Long Island Physician Holdings Corporation
         Consolidated Statements of Operations and Accumulated Deficit
            Three and Nine Months Ended September 30, 2003 and 2002
                                  (unaudited)

<TABLE>
<CAPTION>
                                                     Three months ended               Nine months ended
                                                        September 30,                    September 30,
                                              ------------------------------    ------------------------------
                                                    2003            2002              2003           2002
                                                    ----            ----              ----           ----
<S>                                              <C>              <C>             <C>              <C>
Revenues:
  Premiums earned                                38,188,274       40,591,591      116,582,035      117,466,539
  Investment and other income                       190,449          745,417          576,820        1,061,243
                                              -------------    -------------    -------------    -------------
  Total revenues                                 38,378,723       41,337,062      117,158,855      118,527,782
                                              -------------    -------------    -------------    -------------
Expenses:
  Medical claims expense                         31,951,760       36,919,343       99,143,927      102,427,675
  Commissions expense                             1,551,353        1,710,625        4,844,143        4,814,363
  General and administrative expenses             3,370,226        3,852,229       10,721,958       11,936,316
  Depreciation                                       46,593           97,828          130,500          273,279
                                              -------------    -------------    -------------    -------------
  Total expenses                                 36,919,932       42,580,025      114,840,528      119,451,633
                                              -------------    -------------    -------------    -------------
  Operating income before taxes                   1,458,791       (1,243,017)       2,318,327         (923,851)
  Income tax expense                                 31,743           44,320           96,743          109,760
                                              -------------    -------------    -------------    -------------
  Net income(loss)                                1,427,048       (1,287,337)       2,221,584       (1,033,611)

  Minority interest in (income) loss of
    subsidiary                                     (478,053)         393,812         (740,251)         310,083
                                              -------------    -------------    -------------    -------------
  Net income (loss)                                 948,995         (893,525)       1,481,333         (723,528)

  Accumulated deficit, beginning of period      (10,109,867)      (9,507,630)     (10,642,205)      (9,677,627)
                                              -------------    -------------    -------------    -------------
  Accumulated deficit, end of period          $  (9,160,872)   $ (10,401,155)   $  (9,160,872)   $ (10,401,155)
                                              =============    =============    =============    =============
  Basic and diluted income per share          $      162.53    $     (153.03)   $       253.7    $     (123.91)
  Basic and diluted weighted average shares           5,839            5,839            5,839            5,839
</TABLE>

The accompanying notes are an integral part of these statements


                                       3
<PAGE>

                   Long Island Physician Holdings Corporation
                      Consolidated Statements of Cash Flows
                  Nine Months Ended September 30, 2003 and 2002
                                   (unaudited)

                                                         Nine months ended
                                                            September 30,
                                                         2003           2002
                                                     -----------    -----------
Cash flows from operating activities:
Net  income                                          $ 1,481,333    $  (723,528)
Adjustment to reconcile net income to net cash
provided by operating activities:
  Depreciation                                           130,500        273,279
  Minority interest in (loss) gain of subsidiary         740,251       (310,083)
  Payments in excess of capitation                     1,517,041        357,374
  Reinsurance recoverable                                117,083        461,109
  Premium receivables                                 (4,047,441)     1,260,220
  Prepaid expenses and other current assets             (180,049)      (886,747)
  Medical claims payable                              (2,812,736)      (339,691)
  Public goods payable                                 1,830,907      1,916,697
  Unearned premium revenue                              (156,482)     1,189,809
  Accounts payable and accrued interest                  698,989     (1,487,636)
                                                     -----------    -----------
Net cash (used in) provided by operating activities     (680,604)     1,710,803
                                                     -----------    -----------
Cash flows from investing activities:
Decrease (Increase) in restricted cash and
investments                                               70,452        (42,745)
Purchase of Property and Equipment                       (33,794)       (35,966)
                                                     -----------    -----------
Net cash (used in) provided by investing activities       36,658        (78,711)
                                                     -----------    -----------
Cash flows from financing activities:
Payments on capital lease obligations                    (12,398)       (31,592)
                                                     -----------    -----------
Net cash used in financing activities                    (12,398)       (31,592)
                                                     -----------    -----------
Net change in cash and cash equivalents                 (656,344)     1,600,500
                                                     -----------    -----------
Cash and cash equivalents, beginning of year             694,449      1,958,090
                                                     -----------    -----------
Cash and cash equivalents, end of year               $    38,105    $ 3,558,590
                                                     -----------    -----------

The accompanying notes are a integral part of these statements


                                       4
<PAGE>

                   Long Island Physician Holdings Corporation
                        Notes to the Financial Statements
                                   (unaudited)


1.  BASIS OF PRESENTATION

      Background

      Long Island Physician Holdings Corporation (the "Company" or "LIPH") was
formed in December 1994 in the State of New York as a holding company for
purposes aimed at advancing the delivery of healthcare on Long Island, New York
(Nassau and Suffolk counties). The Company is owned by individual physicians
residing in New York State. The accompanying consolidated financial statements
include the activity of the Company and its majority owned subsidiary, MDNY
Healthcare, Inc. ("MDNY"), a health maintenance organization. The Company owns
67% of stock of MDNY. The Company is exclusively a holding company whose
principal assets is its investment in MDNY and conducts no operating activities
of its own. The Company's legal and other professional costs are funded by MDNY.

      Basis of Presentation

      The interim consolidated financial statements reflect all adjustments,
which, in the opinion of management, are necessary for a fair statement of
financial condition and results of operations for the periods presented. Except
as otherwise disclosed, all such adjustments are of a normal recurring nature.
The interim consolidated financial statements have been compiled without audit.
Operating results for the interim periods are not necessarily indicative of the
results that may be expected for the full year. These interim consolidated
financial statements should be read in conjunction with the audited consolidated
financial statements included in the Company's 2002 Annual Report on Form 10-K.
Certain amounts reported in the Company's consolidated statements of operations
for the nine months ended September 30, 2002 have been reclassified to conform
to the 2003 presentation.

      Earnings Per Share

      Basic and diluted income per share is based on the number of shares of
Class A common stock and Class B common stock outstanding during the period. At
September 30, 2003 and 2002, the Company had outstanding stock options to
purchase 1,041 shares of Class B common stock that were not included in the
computation of diluted earnings per share because the exercise price was greater
than the average market price of common share.

      New Accounting Standards

      In April 2002, the Financial Accounting Standards Board ("FASB") issued
SFAS No. 145, "Rescission of FASB Statements No. 4, 44, and 64, Amendment of
FASB Statement No. 13, and Technical Corrections" ("SFAS 145"). SFAS 145
rescinds SFAS No. 4, "Reporting Gains and Losses from Extinguishment of Debt"
("SFAS 4"), SFAS No. 44, "Accounting for Intangible Assets of Motor Carriers"
("SFAS 44") and SFAS No. 64, "Extinguishments of Debt Made to Satisfy
Sinking-Fund Requirements" ("SFAS 64") and amends SFAS No. 13, "Accounting for
Leases" ("SFAS 13"). This statement updates, clarifies and simplifies existing
accounting pronouncements. As a result of rescinding SFAS 4 and SFAS 64, the
criteria in APB Opinion No. 30, "Reporting the Results of Operations-Reporting
the Effects of Disposal of a Segment of a Business, and Extraordinary, Unusual
and Infrequently Occurring Events and Transactions", is used to classify gains
and losses from extinguishment of debt. SFAS 44 was no longer necessary because
the transitions under the Motor Carrier Act of 1980 were completed. SFAS 13 was
amended to eliminate an inconsistency between the required accounting for
sale-leaseback transactions and the required accounting for certain lease
modifications that have economic effects that are similar to sale-leaseback
transactions and makes technical corrections to existing pronouncements. The
provisions of SFAS 145 are effective for fiscal years beginning after May 15,
2002. The Company's adoption of SFAS 145 effective January 1, 2003, did not have
a material impact on the Company's results of operations or financial position.

      In July 2002, the FASB issued SFAS No. 146, "Accounting for Costs
Associated with Exit or Disposal Activities" ("SFAS 146"), which addresses the
recognition, measurement, and reporting of costs associated with exit or
disposal activities, and supercedes Emerging Issues Task Force Issue No. 94-3,
"Liability Recognition for Certain Employee Termination Benefits and Other Costs
to Exit an Activity (including Certain Costs Incurred in a Restructuring)"
("EITF 94-3"). The principal difference between SFAS 146 and EITF 94-3 relates
to the requirements for recognition of a liability for a


                                       5
<PAGE>

                   Long Island Physician Holdings Corporation
                        Notes to the Financial Statements
                                   (unaudited)

cost associated with an exit or disposal activity. SFAS 146 requires that a
liability for a cost associated with an exit or disposal activity, including
those related to employee termination benefits and obligations under operating
leases and other contracts, be recognized when the liability is incurred, and
not necessarily the date of an entity's commitment to an exit plan, as under
EITF 94-3. SFAS 146 also establishes that the initial measurement of a liability
recognized under SFAS 146 be based on fair value. The provisions of SFAS 146 are
effective for exit or disposal activities that are initiated after December 31,
2002. The Company adopted SFAS 146 effective January 1, 2003.

      In November 2002, the FASB issued Interpretation No. 45, "Guarantor's
Accounting and Disclosure Requirements for Guarantees, Including Indirect
Guarantees of Indebtedness of Others" ("FIN 45"). FIN 45 requires a guarantor to
recognize a liability, at the inception of the guarantee, for the fair value of
obligations it has undertaken in issuing the guarantee and also include more
detailed disclosures with respect to guarantees. FIN 45 is effective on a
prospective basis for guarantees issued or modified starting January 1, 2003 and
requires the additional disclosures in interim and annual financial statements
effective for the period ended December 31, 2002. The Company's adoption of the
initial recognition and measurement provisions of FIN 45 effective January 1,
2003, did not have a material impact on the Company's results of operations or
financial position.

      In January 2003, the FASB issued Interpretation No. 46 ("FIN 46"),
"Consolidation of Variable Interest Entities". FIN 46 requires a variable
interest entity to be consolidated by a company if that company is subject to a
majority of the risk of loss from the variable interest entity's activities or
entitled to receive a majority of the entity's residual returns or both.
Historically, entities generally were not consolidated unless the entity was
controlled through voting interests. FIN 46 also requires disclosures about
variable interest entities that a company is not required to consolidate but in
which it has a significant variable interest. The consolidation requirements of
FIN 46 apply immediately to variable interest entities created after January 31,
2003. On October 8, 2003, the FASB deferred the implementation date for FIN 46
as it relates to variable interest entities that existed prior to February 1,
2003. The consolidation requirements of FIN 46 will apply to variable interest
entities that existed prior to February 1, 2003 in financial statements issued
for periods ending after December 15, 2003 (December 31, 2003 for the Company).
Also, certain disclosure requirements apply to all financial statements issued
after January 31, 2003, regardless of when the variable interest entity was
established. The adoption of this standard is not expected to have a material
impact on the Company's consolidated financial statements.

      In April 2003, the FASB issued SFAS No. 149, "Amendment of Statement 133
on Derivative Instruments and Hedging Activities" ("SFAS 149"), which amends and
clarifies financial accounting and reporting for derivative instruments,
including certain derivative instruments embedded in other contracts, and for
hedging activities under SFAS 133. SFAS 149 is effective for contracts entered
into or modified after September 30, 2003, and for hedging relationships
designated after September 30, 2003. The adoption of SFAS 149, effective July 1,
2003, did not have a material impact on the Company's results of operations or
financial position.

      In May 2003, the FASB issued SFAS No. 150, "Accounting for Certain
Instruments with Characteristics of both Liabilities and Equity" ("SFAS 150"),
which establishes standards for how an issuer classifies and measures certain
financial instruments with characteristics of both liabilities and equity. SFAS
150 is effective for financial instruments entered into or modified after May
31, 2003, and otherwise is effective at the beginning of the first interim
period beginning after September 15, 2003. The Company's adoption of the initial
recognition and initial measurement provisions of SFAS 150, effective September
1, 2003, did not have a material impact on the Company's results of operations
or financial position.


                                       6
<PAGE>

                   Long Island Physician Holdings Corporation
                        Notes to the Financial Statements
                                   (unaudited)

2. REGULATORY DEVELOPMENTS

      As a condition of continued licensure by the New York State Insurance
Department ("NYSID"), MDNY must maintain certain reserve requirements to protect
its subscribers in the event MDNY is unable to meet its obligations. As of
September 30, 2003, MDNY continued to not satisfy its NYSID statutory net worth
requirement of $7.8 million by approximately $650,000. As a result of the
impairment, NYSID directed MDNY to take appropriate action to achieve net worth
of at least $7 million (MDNY's escrow deposit requirement) by July 10, 2003. On
May 14, 2003, NYSID directed MDNY to provide monthly financial statements. MDNY
failed to meet the $7 million funding requirement by July 10, 2003 and NYSID
continues to monitor MDNY's financial performance.

3. GOING CONCERN

      The Company's financial statements have been presented on the basis that
it will continue as a going concern, which contemplates the realization of
assets and the satisfaction of liabilities in the normal course of business. The
Company has a substantial working capital deficit and has incurred cumulative
losses since inception. Furthermore, the Company has utilized substantially all
of the cash raised in its initial equity infusion in funding its operations and
currently is deficient in its contingent reserve fund (see footnote 5) by
approximately $3 million at December 31. 2002.

      As a result of this deficiency, the New York State Insurance Department
("NYSID") issued a letter dated April 10,2003 whereby the NYSID directed the
Company to fund the net worth to at least $7 million by July 10, 2003. The
Company has been and continues to explore investment alternatives to remedy its
impairment and will update the NYSID as to the Company's progress towards
meeting deadlines imposed by the NYSID.

      During the second quarter 2000, the NYSID performed its first financial
audit of MDNY and its affiliated IPA's as of June 30, 2000. On May 10, 2001,
MDNY received from NYSID a Draft Report on Examination of MDNY as of June 30,
2000 (the "Draft Report"). The Draft Report stated, among other things, NYSID'S
determinations that, as of June 30, 2000, MDNY was insolvent in the amount of
$4,311,487 and that MDNY'S required contingency reserves were impaired in the
amount of $12,231,333. These determinations resulted from NYSID's position


                                       7
<PAGE>

                   Long island Physician Holdings Corporation
                   Notes to Consolidated Financial Statements

that MIDNY should have reported that IPA's obligations in MDNY's financial
statements. MDNY's position was that the IPAs, not MDNY, are responsible for
their own obligations, and MDNY disputed NYSID's attribution of IPA liabilities
to MDNY.

      On July 31, 2002, NYSID issued its Report on Examination of The MDNY
Healthcare, Inc. as of June 30, 2000 dated April 2,2001 and revised July 31,
2002 (the "Final Report"). The Final Report states, among other things, that,
based on the execution of a Recovery and Subordination Agreement between the
Company and the NYSID, the NYSID permitted an IPA receivable to be recognized as
an admitted asset for medical claims paid by MDNY in excess of negotiated
Capitated Arrangement ("Payments in Excess of Capitation") and MDNY agrees to
enter into full-risk contracts with the IPA's and the examination insolvency was
eliminated.

      Through 2001, MDNY continued to pay medical claims to Island IPA
participating providers relating to claims with dates to service prior to
January 1, 2001 in excess of capitated amounts for years prior to 2001. These
paid amounts have resulted in a net amount due from Island IPA of approximately
$22.2 million and $23.2 million, which is included in the balance sheet as
Payments in Excess of Capitation as of December 31, 2002 and 2001, respectively.

      In accordance with the Recovery and Subordination Agreement, these amounts
owed to MDNY are being reduced as follows:

      o     Island IPA for itself and on behalf of each of its participating
            providers and Catholic Health Services of Long Island ("CHS") and
            its hospital affiliates (collectively the "Subordinating Parties")
            agree to subordinate their rights to payment of outstanding claims
            (including IBNR) owed by MDNY to all other creditors in the event of
            MDNY's insolvency. The aggregate amounts owed to these Subordinating
            Parties in the form of medical claims payable as of December 31,
            2002 and 2001 were approximately $25,000,000 and $24,600,000,
            respectively. The aggregate amount of this subordination is equal to
            the amounts owed to those Subordinating Parties in the form of
            medical claims payable at the time MDNY becomes insolvent.

      o     Effective January 1, 2002, Island IPA began retaining a
            non-distributable withhold in the amount of 5% of payments to
            participating providers and Island IPA has remitted the entire
            amount of the withheld on a monthly basis to MDNY. During 2002, the
            amount remitted to MDNY reduced the payments in excess of capitation
            receivable by approximately $2 million.

      o     Island IPA is obligated to pay MDNY a portion of all income it
            receives from sources other than MDNY. Such payments will be in an
            amount equal to gross collections minus operational and
            administrative expenses (the "Net Revenues") received by Island IPA
            from such sources.

      o     The withhold remittances, network access fee and net fee described
            above will remain in effect until such time as the repayment of the
            debt to MDNY has been fully satisfied.


                                       8
<PAGE>

                   Long Island Physician Holdings Corporation
                   Notes to Consolidated Financial Statements

      During 2003, the Company is in the process of negotiating certain
transactions that includes a potential transaction with a third party and has
implemented certain plans in order to provide liquidity to the Company and
achieve combined profitability. A summary of these transactions and plans is as
follows:

      o     The Company received a premium rate increase of 20%, effective
            January 1, 2003.

      o     Management has initiated efforts to reduce operating and medical
            expenses during 2003, primarily relating to staffing reductions and
            renegotiation of provider contracts.

      While management believes that implementation of its plans to achieve
profitability will provide them with the ability to continue as a going concern,
there is no assurance that such actions will achieve positive results from
operations or adequate working capital and equity.

      As of September 30, 2003 MDNY reported a net operating gain of $1,481,333
and a GAAP net worth of $4.3 million; a statutory net worth of $7.2 million. The
contingent reserve requirement at September 30, 2003 and December 31, 2002 was
$7.8 million. (NYSID reserve requirements are calculated, at December 31 and is
based upon the greater of the contingent reserve or escrow deposit. The
contingent reserve is calculated by incrementally adding 1% of premiums written
not to exceed 5% (i.e., $7.8 million). The escrow deposit is calculated as 5% of
the following year's expected medical costs.

      In June 2003, NYSID revised and finalized its Market Conduct Report on
Examination of MDNY as of September 30, 2002 and made recommendations regarding
certain operational deficiencies found in MDNY's policies and procedures. MDNY
continues to file a report every 90 days updating NYSID of progress made on
deficiencies noted in the report.


                                       9
<PAGE>

Item 2. Management's Discussion and Analysis of Financial Condition and Results
        of Operations

Results of Operations

Company Overview

      Long Island Physician Holdings Corporation (the "Company" or "LIPH") is a
New York corporation formed in December 1994 and owned by physicians residing
and practicing in New York State. The Company conducts no operating activities
of its own. The Company's principal asset is 67% of the stock in MDNY
Healthcare, Inc. ("MDNY"), an independent practice association-model health
maintenance organization ("HMO"), that currently operates in Nassau and Suffolk
counties, New York. The financial statements of MDNY are consolidated into the
audited financial statements of the Company. Catholic Healthcare Network of Long
Island, Inc. ("CHNLI") owns the remaining 33% of the stock in MDNY. MDNY
commenced operations in 1996. At September 30, 2003, MDNY had approximately
50,125 members ("Members"), comprised of individuals and families, enrolled in
its health maintenance plans and point-of-service plans. As of December 31, 2002
membership was approximately 62,000.

      The Company is affiliated with LIPH, LLC (the "LLC"), a New York limited
liability company formed in December 1996. Upon the formation of the LLC, the
shareholders of the Company owned all of the membership interests in the LLC.
The assets of the LLC consist of the stock in three independent practice
associations, Island Practice Association, IPA, Inc. ("Island IPA"), Island
Behavioral Health Association IPA, Inc. (currently inactive) and Island Dental
Professional Association IPA, Inc. (the "IPAs"). MDNY has entered into various
contractual arrangements (the "Professional Services Agreements") with the IPAs
to arrange for the provision of applicable health care and administrative
services to the Members of MDNY. During 2001 certain other single specialty IPAs
whose providers were also participating providers to Island IPA were dissolved.

      MDNY's principal source of revenue is premiums earned. Premiums earned
represented 99% and 98% of MDNY's total revenue for the quarters ended September
30, 2003 and 2002, respectively.

      MDNY's ability to achieve profitability depends principally on reducing
its medical expenses as a percentage of its premium revenue (the "medical loss
ratio" or "MLR") and sufficiently reducing its administrative costs. During
2002, MDNY continued to implement programs to reduce administrative costs.
Although MDNY was able to reduce its administrative costs by $4 million or 22%,
(on a per member per month basis) as a result of the increase in membership
associated with sole proprietors which historically have higher medical costs
than the small group market, medical costs increased 9% and commissions
increased 19%. Commissions paid to general agents and associations increased
over 2002 because the sole proprietor market prior to September 2002 could only
enroll through associations. These increases offset any savings realized on
administrative costs resulting in a net loss reported at December 31, 2002 of
$1.4 million.

      As of September 30, 2003, the reported profit of approximately $1,481,333
is the result of administrative savings implemented in the last half of 2002
together with the loss in POS membership and premium rate increases that became
effective in 2003. The Company believes limiting the marketing of the POS plan
in 2003 because of historic losses helped achieve profitability as of September
30, 2003.

      MDNY seeks to control medical expenses through arrangements with its
affiliated IPAs and with non-IPA primary care physicians, with certain specialty
providers, and through its quality improvement programs, utilization management
and review of hospital inpatient and outpatient services, and educational
programs on effective managed care for its providers. MDNY's medical loss ratio
was 84.6% and 86.4%, respectively, for the nine months ended September 2003 and
2002. As of September 30, 2003 and 2002 enrollment was 50,125 and 61,988
respectively.

      MDNY's working capital deficit decreased from $22.3 million at December
31, 2002 to $18.3 million at September 30, 2003 primarily due to earnings
generated during 2003.


                                       10
<PAGE>

Recent Developments

      Certain Regulatory Matters.

      The New York State Department of Health ("NYSDOH") and the New York State
Insurance Department ("NYSID"), require MDNY to maintain reserves in the form of
cash and statutory net worth.

      During the second quarter 2000, the NYSID performed its first financial
audit of MDNY and the IPAs as of June 30, 2000. On May 10, 2001, MDNY received
from NYSID a Draft Report on Examination of MDNY as of June 30, 2000 (the "Draft
Report"). The Draft Report stated, among other things, NYSID's determinations
that, as of June 30, 2000, MDNY was insolvent in the amount of $4,311,487 and
that MDNY's required contingency reserves were impaired in the amount of
$12,231,333. These determinations resulted from NYSID's position that MDNY
should have reported the IPAs' obligations in MDNY's financial statements.
MDNY's position was that the IPAs, not MDNY, are responsible for their own
obligations, and MDNY disputed NYSID's attribution of IPA liabilities to MDNY.

      With respect to years prior to 2001, MDNY was contractually obligated to
pay a capitated amount to Island IPA for covered services provided by
participating providers. Through 2001, however, MDNY continued to pay medical
claims to Island IPA relating to claims with dates of service prior to January
1, 2001 in excess of capitated amounts for years prior to 2001. These payments
resulted in a net amount due from Island IPA of approximately $24 million as of
December 31, 2001. This amount due from Island IPA has been reduced to $20.7
million and $22.2 million, as reflected in MDNY's financial statements as
payments in excess of capitation as of September 30, 2003 and December 2002,
respectively. The reduction in amounts due from Island IPA is the result of a 5%
withhold on all IPA participating provider claims, described below. NYSID's
position was that this receivable, payments in excess of capitation, should be
written off, causing MDNY to be deficient in its reserves.

      In order to meet NYSID's concerns, MDNY converted the capitation-based
contract with Island IPA to a fee for service based IPA Participation Agreement
effective January 1, 2001.

      In addition with NYSID's approval, MDNY, Island IPA and the Catholic
Health System of Long Island, Inc. ("CHSLI"), an affiliate of CHNLI, on behalf
of five catholic hospitals that act as providers to MDNY (the "Hospitals"),
entered into a Recovery and Subordination Agreement (the "Recovery Agreement"),
dated July 12, 2001 and effective January 1, 2002. Pursuant to the Recovery
Agreement: (i) Island IPA is required to pay the Island Debt pursuant to a
Repayment Plan, whereby MDNY is obligated to withhold 5% of all revenues payable
to Island IPA participating providers, Island IPA is required to pay MDNY a
$1.50 per member per month network access fee, and Island IPA is required to pay
to MDNY the net revenue it receives from sources other than MDNY; (ii) until the
Island Debt is repaid, Island IPA, Island IPA's participating providers and the
Hospitals agreed that if MDNY becomes insolvent (pursuant to a court approved
order or admits its inability to pay its debts), their claims against MDNY will
be subordinated to all other outstanding claims in an amount equal to the amount
of the then outstanding Island Debt, and that, after payment of third party
claims, the claims of Island IPA and its providers will be subordinated to the
claims of the Hospitals; and (iii) the amount of the Island Debt outstanding
from time to time will be carried on the financial statements of MDNY as an
admitted asset [payments in excess of capitation].

      On July 31, 2002, NYSID issued its Report on Examination of The MDNY
Healthcare, Inc. as of June 30, 2000 dated April 2, 2001 and revised July 31,
2002 (the "Final Report"). The Final Report states, among other things, that,
based on the execution of the Recovery Agreement, "the IPA receivable will be
allowed as an admitted asset and the examination insolvency will be eliminated.
[NYSID] will monitor the impact of the [Recovery] Agreement."

      In January 2003, NYSID notified MDNY that MDNY was impaired by the amount
of $850,332 at September 30, 2002 and required MDNY to submit a restoration plan
to remedy the impairment. (Impairment is the amount by which reported net worth
is less than the amount of required reserves). In February 2003, MDNY submitted
a remedial plan (the "MDNY Remedial Plan") to NYSID whereby: MDNY would continue
negotiations with certain potential acquirors regarding a proposed sale of MDNY;
MDNY would engage an investment banking firm; the Company and CHNLI, as the
stockholders in MDNY, would be offered the alternative of making additional
capital contributions to MDNY or selling all or part of MDNY; and the IPA
providers had agreed to reduce the physician fee schedule effective April 1,
2003. In April 2003, NYSID accepted the MDNY Remedial Plan. MDNY engaged an
investment banking firm in October 2003 to pursue the sale of MDNY.


                                       11
<PAGE>

      As of September 30, 2003 MDNY reported a net operating gain of $1,481,333
and a GAAP net worth of $4.3 million; a statutory net worth of $7.2 million. The
contingent reserve requirement at September 30, 2003 and December 31, 2002 was
$7.8 million. (NYSID reserve requirements are calculated, at December 31 and is
based upon the greater of the contingent reserve or escrow deposit. The
contingent reserve is calculated by incrementally adding 1% of premiums written
not to exceed 5% (i.e., $7.8 million). The escrow deposit is calculated as 5% of
the following year's expected medical costs.

      On April 1, 2003, with the filing of the December 31, 2002 Annual Report,
NYSID was notified that MDNY was impaired by $3 million. As a result of the
impairment NYSID directed MDNY to take appropriate action to achieve net worth
of at least $7 million (MDNY's escrow deposit requirement) by July 10, 2003. On
May 14 2003, NYSID directed MDNY to provide monthly financial statements. As of
September 30, 2003, MDNY had satisfied this directive.

      In June 2003, NYSID revised and finalized its Market Conduct Report on
Examination of MDNY as of September 30, 2002 and made recommendations regarding
certain operational deficiencies found in MDNY's policies and procedures. As of
November 2003, the NYSID continues to monitor MDNY's performance.

      The failure of MDNY to meet reserve requirements, the failure of MDNY or
the IPAs to comply with other existing laws and regulations or a significant
change in such laws or regulations could materially and adversely affect the
operations, financial condition and prospects of the Company and MDNY.

      According to the NYSID Final Report, the composition of MDNY's Board of
Directors does not comply with Part 98-1.11(f) of the Administrative Rules and
Regulation of the NYSDOH, which requires that at least 20% of MDNY's directors
must be enrollees of MDNY. The NYSID Final Report recommends that the requisite
number of "enrollee representatives" be elected to MDNY's Board of Directors.
MDNY and its shareholders, LIPH and CHNLI, are in the process of changing the
composition and number of MDNY's Directors so as to include the requisite number
of enrollee representatives and of effecting corresponding amendments to MDNY's
certificate of incorporation and by-laws.

Business Strategy

      In order to improve liquidity and achieve profitability, MDNY reduced the
IPA's physician fee schedule effective April 1, 2003 in order to support
improved operating results in 2003. The fee schedule reduction was implemented
effective May 15, 2003. In addition, NYSID approved an additional 10% rate
increase for MDNY's sole proprietor Members effective June 1, 2003.

      In addition, MDNY historically had negative operating results on its POS
plans while achieving profitability on its HMO plans. As a result of the
significant premium rate increases on POS plans for 2003 (approximately 40%) POS
membership decreased 48% and the HMO decreased 11% as of September 30, 2003 from
December 31, 2002 respectively. The significant decrease in POS products
improved profitability for MDNY for the period ending September 30, 2003.

      While the Company believes that implementation of MDNY's plans will
achieve profitability in 2003, there is no assurance that such actions will
achieve positive results from operations or adequate working capital and equity.

      In accordance with the MDNY Remedial Plan, MDNY is actively pursuing the
sale of its business and assets. However, there can be no assurance that any
such sale will be completed on terms acceptable to MDNY, if at all.


                                       12
<PAGE>

The following table provides certain statement of operations data expressed as a
percentage of total revenue and other statistical data for the nine-month period
ended September 30, 2003 and 2002:

                                                      2003                2002
                                                      ----                ----
Revenues:
Premiums earned                                       99.5%               99.1%
Investment and other income                            0.5                  .9
                                                     -----               -----
     Total revenue                                   100.0               100.0
                                                     -----               -----
Medical claims expense                                84.6                86.4
Commissions expense                                    4.1                 4.1
General and administrative expenses                    9.2                10.1
Depreciation                                            .1                 0.2
                                                     -----               -----
     Total expenses                                   98.0               100.8
                                                     -----               -----
Operating before income taxes                          2.0                 (.8)

Income tax expense                                      .1                 0.1
                                                     -----               -----
Net income before minority interest                    1.9                 (.9)

Minority interest in income of subsidiary             (0.6)                 0.3
                                                     -----               -----
Net income                                             1.3%               (0.6)%
                                                     -----               -----
Statistical data:
     Enrollment (HMO and POS)                       50,125              61,988
     HMO enrollment                                 42,656              47,146
     POS enrollment                                  7,559              14,842
     ASO enrollment                                  3,640               3,487
    ^Member months                                 482,183             525,584
    *Medical loss ratio                               84.6                86.4
   **Administrative loss ratio                        13.4                14.4

*  Medical loss ratio- Medical expense and net reinsurance divided by total
   premium

** Administrative loss ratio-Commission expense, depreciation, and general
   administrative expense divided by total premium

^  does not include ASO member months which is dental only

Comparison of three months ended September 30, 2003 and revenues for the quarter
ended September 30, 2003 were $38,379,000 down 7% from $41,337,000 during the
same period in the prior year. Enrollment totaled 50,125 at September 30, 2003
down 20% from 61,988 at September 30, 2002. Premium revenues decreased
$2,400,000 or 6% as a result of this decline in enrollment offset by premium
rate increases. In addition, although enrollment in the POS products dropped to
7,559 from 14,842 at September 30, 2002, MDNY was approved for a 10%
differential in sole proprietor rates effective September 1, 2003 which helped
offset anticipated declines in premium related to the drop in enrollment.
Premium yields for the third quarter increased 13% to $252 on a pmpm (per member
per month) basis from $223 compared to the third quarter 2002.


                                       13
<PAGE>

      Total expenses for the quarter ended September 30, 2003 were $36,900,00
down 13% from $42,580,000 for the same period in the prior year. This decrease
in expenses is the result of enrollment declines realized during the third
quarter.

       Medical claim expense as a percent of premium revenues was 83.3% for the
third quarter 2003 compared to 89.3% for the third quarter 2002. Medical costs
stated on a pmpm basis increased to $211 for the third quarter 2003 from $203
during the same period in the prior year; a 4% increase.

      Commissions as a percent of premium remained at 4% for the third quarter
2003 and third quarter 2002. Although enrollment decreased during the second
quarter 2003, the percentage of enrollment generated through associations
remained approximately 48%.

      Net income for the third quarter of 2003 totaled $948,995, compared with a
net loss of $893,525 for the third quarter 2002. Higher premium yields realized
in 2003 and lower than anticipated medical cost increases contributed to the
overall increase in net earnings reported in the third quarter.

      Comparison of nine months ended September 30, 2003 and 2002

      Total revenues for the nine months ended September 30, 2003 were
$117,160,000, down 1% from $118,530,000 during the same period in the prior
year. MDNY's commercial enrollees totaled approximately 50,215 as compared to
approximately 61,988 for the same period in 2002. Revenue decreased $1.4 million
for the nine months ended 2003 compared to the same period in 2002; a decline of
1%. This revenue decrease was primarily the result of the overall 20% decrease
in enrollment partially offset by premium rate increases . In addition, during
2002 MDNY received a $400,000 pharmacy rebate settlement, a non recurring item
that contributed to the 45% decrease in other operating revenue to $576,000 for
the nine months ended September 30, 2003. Total member months for the period
ended September 30, 2003 decreased approximately 43,400 or 8% from the same
period in 2002. Although the enrollment declined 20% the overall premium yields
on a pmpm basis increased 8% to $241 versus 223 for the same comparative time
period.

      Total expenses for the period ended September 30, 2003 were $114,840,000,
down 4% from $119,450,000 for the same period in the prior year. This overall 4%
decrease in expenses is also the result of the overall 20% decrease in
enrollment. As of December 31, 2002 MDNY had approximately 62,000 enrollees. As
of September 30,2003 enrollment had declined to 50,215. Although the enrollment
declined 20% the overall medical expense on a pmpm increased 6% to $205.61 from
$194.89 as of September 30, 2003 and September 30, 2002 respectively.

      Medical claim expense stated as a percentage of premium revenues was 84.6%
for the period ended September 30, 2003 compared with 86.4% for the nine months
ended September 30, 2002.

      Commissions and administrative expenses stated as a percentage of premium
revenue was 13.4% for the period ended September 30, 2003 compared with 14.4%
for the same period in the prior year. Total administrative expenses decreased
$1.3 million for the nine months ended 2003 compared to the same period in 2002.
This reduction was the result of reductions in staffing realized in the first
quarter of 2003 together with operational efficiencies focused on by MDNY
throughout 2002 offset by increasing commission costs.

      Net income for the period ended September 30, 2003 was $1,481,333 compared
to a net loss of $723,528 for the same period in the prior year. This increase
in net income is primarily the result of overall increase in premium yields
realized in 2003 offset by lower than anticipated medical costs and
administrative costs in 2003 compared to 2002.

      Liquidity and Capital Resources

      Cash and cash equivalents for the nine months ended September 30, 2003
decreased to $38,105 from $694,449 at December 31, 2002. The decrease in net
cash and cash equivalents is related to the timing of payment claims and other
liabilities offset by delays in the collection of premium receivables resulting
from slower paying hospitals.

      MDNY had a negative working capital of $18,335,974 at September 30, 2003
compared to a negative working capital of $22,316,000 at December 31, 2002. The
negative working capital decreased as of September 30, 2003 primarily due to
earnings generated during 2003. The Company anticipates that 2003 rate increases
together with the other operating initiatives described above under the caption
"Business--Business Strategy" will produce sufficient cash flows to meet MDNY's
obligations. There can be no assurance that MDNY will be able to achieve
sufficient cash flows.

      Capital Reserves and Liquidity

      Certain matters relating to MDNY's regulatory status, its compliance with
applicable reserve and statutory net worth requirements and liquidity are
discussed above under the captions "Business--Recent Developments" and
"--Business Strategy."


                                       14
<PAGE>

      The continued failure of MDNY to meet reserve requirements, the failure of
MDNY or the IPAs to comply with other existing laws and regulations or a
significant change in such laws or regulations could materially and adversely
affect the operations, financial condition and prospects of the Company, MDNY
and the IPAs.

      MDNY obtained a Section 1307 loan from LIPH, LLC for $1 million in 1997
and another from CHNLI for $1.4 million in 1998. Interest on these loans accrues
at the prime rate and are payable quarterly. See Note 7 to the Consolidated
Financial Statements included elsewhere herein. These loans together with the
accrued interest brought MDNY's September 30, 2003 to a statutory net worth of
$7.2 million compared to the NYSID required net worth of $7.8 million. (Under
Section 1307, the principal and interest are treated as equity capital for
regulatory purposes and are repayable out of free and divisible surplus, subject
to the prior approval of NYSID).

      Critical Accounting Policies and Estimates

      The preparation of financial statements in conformity with accounting
principles generally accepted in the United States requires the Company to make
estimates and assumptions and select accounting policies that affect the
reported amounts of assets and liabilities and disclosure of contingent assets
and liabilities at the date of the financial statements, as well as the reported
amounts of revenues and expenses during the reporting period. Actual results
could differ from those estimates.

      While many operational aspects of MDNY's business are subject to complex
federal, state and local regulations, the accounting for the Company's business
is generally straightforward with revenues primarily recognized during the
period in which MDNY is obligated to provide services to subscribers. Premiums
collected in advance are deferred and recorded as unearned premium revenue in
the balance sheet. Due to the nature of MDNY's business, several of the
Company's accounting policies, primarily relating to costs of claims incurred
but not reported and allowance for doubtful accounts associated with premium and
reinsurance receivables, involve significant estimates and judgments. These
accounting policies have been described in our 2002 Annual Report on Form 10-K.

      Factors affecting future results

      Health Insurance Portability and Accountability Act of 1996

      The Secretary of the Department of Health and Human Services, or HHS, has
issued final regulations under the Health Insurance Portability and
Accountability Act of 1996 ("HIPAA"), designed to improve the efficiency and
effectiveness of the health care system by facilitating the electronic exchange
of information in certain financial and administrative transactions while
protecting the privacy and security of the information exchanged. Three
principal regulations have been issued: privacy regulations, security
regulations, and standards for electronic transactions.

      MDNY implemented the HIPAA privacy regulations by April 2003, as required,
and is evaluating the costs of upgrading its systems and procedures to fully
comply with the security regulations by the compliance deadline of April 20,
2005.

      The HIPAA regulations on electronic transactions, which the Company refers
to as the transaction standards, establish uniform standards for electronic
transactions and code sets, including the electronic transactions and code sets
used for claims, remittance advices, enrollment and eligibility. The transaction
standards became effective in October 2002, although covered entities were
eligible to obtain a one-year extension if approved through an application to
the Secretary of HHS. MDNY received this one-year extension through October 16,
2003 from HHS.

      HHS issued Guidance on July 24, 2003 that it will not penalize a covered
entity for post-implementation date transactions that are not fully compliant
with the transactions standards, if the covered entity can demonstrate its good
faith efforts to comply with the standards. HHS' stated purpose for this
flexible enforcement position was to "permit health plans to mitigate unintended
adverse effects on covered entities' cash flow and business operations during
the transition to the standards, as well as on the availability and quality of
patient care."

      There is a divergence of interpretation as to how the new transaction
standards are to be implemented and as a result, MDNY could face increased costs
and complexity, and a temporary disruption in MDNY's business processes. MDNY is
continuing to make good faith efforts to comply with the standards. At this
time, the Company cannot estimate the potential impact of implementing (or
failing to implement) the HIPAA transaction standards on cash flows and results
of operations.

      Impact of New Accounting Standards

      In April 2002, the Financial Accounting Standards Board ("FASB") issued
SFAS No. 145, "Rescission of FASB Statements No. 4, 44, and 64, Amendment of
FASB Statement No. 13, and Technical Corrections". In July 2002, the FASB


                                       15
<PAGE>

issued SFAS No. 146, "Accounting for Costs Associated with Exit or Disposal
Activities". In November 2002, the FASB issued Interpretation No. 45,
"Guarantor's Accounting and Disclosure Requirements for Guarantees, Including
Indirect Guarantees of Indebtedness of Others". In January 2003, the FASB issued
Interpretation No. 46, "Consolidation of Variable Interest Entities". In April
2003, the FASB issued SFAS No. 149, "Amendment of Statement 133 on Derivative
Instruments and Hedging Activities". In May 2003, the FASB issued SFAS No. 150,
" Accounting for Certain Instruments with Characteristics of both Liabilities
and Equity".

      The impact of the above referenced accounting standards is discussed in
Note 1 to the interim consolidated financial statements.

      Inflation

      Medical costs have been rising at a higher rate than that for consumer
goods as a whole. The Company believes that MDNY's premium increases, provider
reimbursement arrangements and other cost control measures mitigate, but do not
wholly offset, the effects of medical cost inflation on MDNY's operations.
MDNY's inability to increase premiums could negatively effect MDNY's future
earnings.


                                       16
<PAGE>

      Certain Factors Affecting Future Operating Results

Certain statements in this Quarterly Report on Form 10-Q are forward-looking
statements and are not based on historical facts but are management's
projections or best estimates. Such forward-looking statements include but are
not limited to, statements concerning future or prospective: results of
operations or financial position, liquidity, health care and administrative
costs, premium rates and yields for commercial business, growth and retention of
membership and development of new lines of business, health care benefits,
provider networks, provider utilization rates, medical loss ratio levels, claims
payment, service performance and other operations matters, administrative loss
ratio levels, proposed efforts to control health care and administrative costs,
impact of agreements with health care providers and related organizations of
providers, reinsurance coverage for risk-transfer arrangements, enrollment
levels, government regulation such as HIPAA, PBOR, the impact of new laws and
regulation, the future of the health care industry, and the impact on MDNY of
regulatory investigations and examinations. Actual results may differ materially
from those expressed or implied by such forward-looking statements due to risks
and uncertainties, including but not limited to the following: MDNY's and the
IPAs' ability to continue as going concerns; the inability of MDNY to meet
applicable reserve and statutory net worth requirements; that MDNY will be
unable to obtain adequate capital investment or effect a sale of its business
and assets on terms acceptable to MDNY, or its shareholders, as the case may be,
if at all; that increased regulation or modification of existing regulations
will increase health care expenses or require additional or increased levels of
statutory reserve requirements; that increased competition in MDNY's markets or
a change in product mix will unexpectedly reduce premium revenue; that MDNY will
not be successful in increasing membership growth; that CHNLI could reconsider
its ability to own stock in MDNY or the Diocese of Rockville Center or any of
the Hospitals affiliated with CHS could elect not to renew their respective
subscriber contracts with MDNY upon expiration in 2005 or 2006, as the case may
be, in light of MDNY's obligation to comply with the New York Women's Health and
Wellness Act, which obligates MDNY to offer contraceptive drugs and devices to
members, in conflict with the ethical policies of the Diocese of Rockville
Center; that health care costs in any given period may be greater than expected
due to general unanticipated increases in health care costs, unexpected
incidence of major cases, national emergencies, natural disasters, epidemics,
changes in physician practices, and new technologies; and that major health care
providers that previously assumed capitation risk from MDNY will be unable to
maintain their operations and reduce or eliminate their accumulated deficits and
MDNY will correspondingly be unable to maintain an adequate provider network.


See also the discussion under "Risks and Uncertainties" in Note 3 of the Notes
to Condensed Consolidated Financial Statements included in this Report and
matters referred to throughout Item 1 of the Company's Annual Report on Form 10K
for the fiscal year ended December 31, 2002.


Item 3. Quantitative and Qualitative Disclosures About Market Risk

See Part I -- Item 2 -- "Management's Discussion and Analysis of Financial
Condition and Results of Operations -- Quantitative and Qualitative Disclosure
About Market Risk."

Item 4. Controls and Procedures

      Based upon an evaluation by the Company's President and Chairman of the
Board and its Chief Financial Officer within 90 days prior to the filing of this
Quarterly Report on Form 10-Q, they have concluded that the Company's disclosure
controls and procedures, as defined in Rule 15d-14(c) under the Securities
Exchange Act of 1934, as amended, are effective for gathering, analyzing and
disclosing information contained in the Company's periodic reports provided to
the Securities and Exchange Commission.

      Subsequent to the Evaluation Date referred to in paragraph 4 of the
Certifications of the Company's principal executive officer and its principal
financial officer included in this report, the Company has not made any change
to its internal controls referred to in paragraph 5 of the Certifications and
there has been no change in other factors that could significantly affect these
controls.


                                       17
<PAGE>

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.
        None.

Item 5. Other Information.
        None.

Item 6. Exhibits and Reports on Form 8-K.
        a. Exhibits

        31(a) Chief Executive Officer Rule 13a-14(a)/15d-14(a) Certification

        31(b) Chief Financial Officer Rule 13a-14(a)/15d-14(a) Certification

        32(a) Chief Executive Officer Section 1350 Certification

        32(a) Chief Financial Officer Section 1350 Certification

(1) Filed herewith.

        b. Reports on Form 8-K.
           None.


                                       18
<PAGE>

                                   SIGNATURES


Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.

      Long Island Physician Holdings Corporation

      By: /s/ PAUL KOLKER, M.D.
          ---------------------------------------------
         Name:   Paul Kolker, M.D.
         Title:  President and Chief Executive Officer


         Date February 4, 2004


                                       19